Home/Pipeline/Oncolytic VSV for Liver Cancer

Oncolytic VSV for Liver Cancer

Liver Cancer (Hepatocellular Carcinoma)

PreclinicalActive

Key Facts

Indication

Liver Cancer (Hepatocellular Carcinoma)

Phase

Preclinical

Status

Active

Company

Humane Genomics

About Humane Genomics

Humane Genomics is a private, preclinical-stage biotech founded in 2018, headquartered in San Diego, CA, USA. The company leverages a proprietary synthetic virology platform to design and build cancer-killing RNA viruses with enhanced selectivity and potency. Its lead programs, focused on liver cancer and other solid tumors, are engineered for systemic delivery and are advancing towards clinical development, supported by key manufacturing and facility partnerships.

View full company profile

Therapeutic Areas

Oncology

Other Liver Cancer (Hepatocellular Carcinoma) Drugs

Drug	Company	Phase	Status
AU-409	Auransa	Phase 1	First-in-human trial ongoing in US; first patient dosed in Asia
CAR-NK-based Cell Therapy	IO Biosciences	Pre-clinical	Active